Proto-oncogene and gap-junction protein expression in rodent liver neoplasms.
Beer
D G
DG
University of Kansas Medical Center, Department of Pharmacology, Toxicology, and Therapeutics, Kansas City 66103.
Neveu
M J
MJ
D000818:Animals; D003043:Cocarcinogenesis; D004052:Diethylnitrosamine / Q000633:toxicity; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D006498:Hepatectomy / Q000009:adverse effects; D007365:Intercellular Junctions / Q000378:metabolism*; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000235:genetics / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D010634:Phenobarbital / Q000633:toxicity; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis*; D016271:Proto-Oncogene Proteins c-myc; D051381:Rats; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains; D005723:gamma-Glutamyltransferase / Q000096:biosynthesis
D009363:Neoplasm Proteins; D011518:Proto-Oncogene Proteins; D016271:Proto-Oncogene Proteins c-myc; D004052:Diethylnitrosamine; D005723:gamma-Glutamyltransferase; D010634:Phenobarbital